NEW YORK (GenomeWeb) – Investment banks Mizuho Securities and William Blair today downgraded Bruker's shares, following the company's announcement that CFO Charles Wagner is resigning effective June 12. 

Mizuho downgraded Bruker to a Neutral rating from a previous Buy rating, while William Blair downgraded the firm to Market Perform from Outperform. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.